The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
C4 Therapeutics, Inc(NASDAQ:CCCC) 
C4 Therapeutics, Inc., a biopharmaceutical company, develops novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable degrader that is in pr...
Website: http://www.c4therapeutics.com
Founded: 2015
Full Time Employees: 88
CEO: Marc A. Cohen
Sector: Other
Industry: Other
C4 Therapeutics Number of Twitter Followers
C4 Therapeutics Days Payable Outstanding ttm (DPO)
C4 Therapeutics Days Receivable Outstanding ttm (DSO)
C4 Therapeutics Days Inventory Outstanding ttm (DIO)
C4 Therapeutics Op Cashflow Per Share ttm
C4 Therapeutics Free Cashflow Per Share ttm
C4 Therapeutics Cash Per Share ttm
C4 Therapeutics P/S ratio ttm
C4 Therapeutics (GAAP) P/E ratio ttm
C4 Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.